Skip to main content
. 2016 Mar 23;6:23636. doi: 10.1038/srep23636

Table 1. Baseline patient characteristics and preoperative risk factors for patients undergoing esophagectomy.

Viariable a All patients N = 166 Group I N = 149 Group II N = 17 P value
Age 60.77 ± 7.66 60.97 ± 7.61 58.94 ± 8.01 0.30
Male 131(78.92%) 116(77.85%) 15(88.24%) 0.53
Body mass index (kg/m2) 22.95 ± 3.24 22.98 ± 3.34 22.61 ± 2.24 0.54
Medical history, n (%)
 Hypertension 41(24.70%) 36(24.16%) 5(29.41%) 0.77
 Diabetes mellitus 16(9.64%) 15(10.07%) 1(5.88%) 1.00
 Respiratory 69(41.57%) 61(40.94%) 8(47.06%) 0.80
 Heart disease 26(15.66%) 20(13.42%) 6(35.29%) 0.03
 Gastrointestinal ulcer 124(75.90%) 110(73.83%) 14(82.35%) 0.57
 Cerebrovescular disease 4(2.41%) 3(2.01%) 1(5.88%) 0.35
 Major surgery 13(7.83%) 12(8.05%) 1(5.88%) 1.00
Duration of presenting symptoms(months) 3.66 ± 7.83 3.36 ± 7.25 6.28 ± 11.71 0.33
Time between diagnosis and surgery (days) 6.80 ± 3.17 6.65 ± 2.69 8.12 ± 5.89 0.32
Weight loss (kg) 1.95 ± 2.74 2.08 ± 2.83 0.77 ± 1.30 0.002
Albumin(g/L) 41.49 ± 2.90 41.36 ± 2.93 42.62 ± 2.36 0.09
Lymphocyte number≥1500( /mm2) 107(64.46%) 97(65.10%) 10(58.82%) 0.60
Hemoglobin(mg/dL) 141.43 ± 12.75 140.71 ± 12.80 147.65 ± 10.75 0.03
Smoking history (ever-smokers) 92(55.42%) 82(55.03%) 10(58.82%) 1.00
Tumor localization, n (%) 0.11
 Upper 15(9.04%) 11(7.38%) 4(23.53%)  
 Middle 57(34.34%) 52(34.90%) 5(29.41%)  
 Lower 94(56.62%) 86(57.72%) 8(47.06%)  
Pulmonary function test
 VC 93.79 ± 16.57 94.66 ± 16.73 87.54 ± 13.12 0.09
 FVC 89.86 ± 15.30 90.71 ± 15.07 83.39 ± 15.52 0.06
 FEV1 95.79 ± 18.31 97.09 ± 17.94 86.18 ± 18.61 0.02
 MVV 87.91 ± 19.65 88.67 ± 18.96 79.60 ± 24.09 0.07
 PEF 88.81 ± 21.25 90.18 ± 20.74 75.67 ± 22.91 0.008
 DLCO 82.46 ± 15.61 82.29 ± 15.73 84.41 ± 15.70 0.59

adata are shown as mean  ±  standard deviation or n (%) as appropriate. VC: vital capacity; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; MVV: maximum ventilator volume; PEF: peak expiratory flow; DLCO: diffusing capacity for carbon monoxide.